A G Marson Selected Research

Epilepsy (Aura)

7/2021	Using routinely recorded data in a UK RCT: a comparison to standard prospective data collection methods.
9/2017	Epilepsy and adverse quality of life in surgically resected meningioma.
7/2017	Risk of a seizure recurrence after a breakthrough seizure and the implications for driving: further analysis of the standard versus new antiepileptic drugs (SANAD) randomised controlled trial.
1/2017	Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access.
7/2015	'Seizure First Aid Training' for people with epilepsy who attend emergency departments, and their family and friends: study protocol for intervention development and a pilot randomised controlled trial.
2/2015	Personalized medicine approaches in epilepsy.
10/2014	A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine.
9/2008	Reporting and analysis of open-label extension studies of anti-epileptic drugs.
4/2008	Clobazam as an add-on in the management of refractory epilepsy.
1/2008	Pregabalin add-on for drug-resistant partial epilepsy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A G Marson Research Topics

Disease

31	Seizures (Absence Seizure) 09/2017 - 01/2000
29	Epilepsy (Aura) 07/2021 - 01/2000
15	Partial Epilepsies (Epilepsy, Partial) 01/2008 - 01/2000
11	Dizziness (Lightheadedness) 01/2008 - 01/2000
8	Drug Resistant Epilepsy 04/2008 - 01/2000
8	Sleepiness 01/2008 - 01/2000
6	Ataxia (Dyssynergia) 01/2008 - 01/2000
5	Fatigue 01/2002 - 01/2000
4	Nausea 01/2002 - 01/2000
3	Anorexia 10/2005 - 01/2000
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 02/2015 - 12/2012
2	Hypersensitivity (Allergy) 02/2015 - 12/2012
2	Diplopia (Double Vision) 01/2001 - 01/2000
1	Neoplasms (Cancer) 09/2017
1	Meningioma (Meningiomas) 09/2017
1	Drug-Related Side Effects and Adverse Reactions 12/2012
1	Weight Gain 01/2008
1	Intellectual Disability (Idiocy) 07/2007
1	Cerebral Malaria 01/2002
1	Tremor (Tremors) 01/2002
1	Accidental Injuries 01/2001
1	Infections 01/2001
1	Myoclonus (Nocturnal Myoclonus) 01/2001
1	Generalized Epilepsy 01/2000

Drug/Important Bio-Agent (IBA)

27	Anticonvulsants (Antiepileptic Drugs)IBA 07/2021 - 01/2000
11	Carbamazepine (Tegretol)FDA LinkGeneric 02/2015 - 01/2000
7	Valproic Acid (Depakote)FDA LinkGeneric 10/2007 - 01/2000
6	Lamotrigine (Lamictal)FDA LinkGeneric 05/2006 - 01/2000
5	Zonisamide (Zonegran)FDA LinkGeneric 10/2007 - 01/2000
4	Levetiracetam (Keppra)FDA LinkGeneric 09/2008 - 01/2001
4	Phenytoin (Dilantin)FDA LinkGeneric 04/2006 - 01/2001
3	Topiramate (Topamax)FDA LinkGeneric 09/2008 - 01/2000
3	Gabapentin (Neurontin)FDA LinkGeneric 09/2008 - 01/2000
3	Phenobarbital (Luminal)FDA Link 01/2003 - 01/2001
2	HLA-B Antigens (HLA-B)IBA 02/2015 - 12/2012
2	Pregabalin (Lyrica)FDA Link 01/2008 - 10/2007
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 04/2006 - 09/2001
2	Ethosuximide (Zarontin)FDA LinkGeneric 10/2005 - 01/2003
2	remacemideIBA 01/2002 - 09/2001
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	Protein Isoforms (Isoforms)IBA 02/2015
1	HLA-A31 antigenIBA 02/2015
1	AntigensIBA 02/2015
1	HLA-A Antigens (HLA-A)IBA 12/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2012
1	Clobazam (HR 376)IBA 04/2008
1	Tiagabine (Gabitril)FDA Link 01/2002
1	Nimodipine (Modus)FDA LinkGeneric 01/2001
1	Nifedipine (Adalat)FDA LinkGeneric 01/2001
1	CalciumIBA 01/2001

Therapy/Procedure

8	Therapeutics 09/2017 - 01/2000
2	Time-to-Treatment 10/2007 - 01/2000
1	Ambulatory Care (Outpatient Care) 07/2021
1	First Aid (Aids, First) 07/2015
1	Precision Medicine 02/2015